These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 20210668
1. Confirmation of association of chromosome 5q31-33 with United Kingdom Caucasian Graves' disease. Simmonds MJ, Yesmin K, Newby PR, Brand OJ, Franklyn JA, Gough SC. Thyroid; 2010 Apr; 20(4):413-7. PubMed ID: 20210668 [Abstract] [Full Text] [Related]
2. The -112G>A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E. Chistiakov DA, Voronova NV, Turakulov RI, Savost'anov KV. J Appl Genet; 2011 May; 52(2):201-7. PubMed ID: 21170691 [Abstract] [Full Text] [Related]
3. Functional SNPs in the SCGB3A2 promoter are associated with susceptibility to Graves' disease. Song HD, Liang J, Shi JY, Zhao SX, Liu Z, Zhao JJ, Peng YD, Gao GQ, Tao J, Pan CM, Shao L, Cheng F, Wang Y, Yuan GY, Xu C, Han B, Huang W, Chu X, Chen Y, Sheng Y, Li RY, Su Q, Gao L, Jia WP, Jin L, Chen MD, Chen SJ, Chen Z, Chen JL. Hum Mol Genet; 2009 Mar 15; 18(6):1156-70. PubMed ID: 19126779 [Abstract] [Full Text] [Related]
4. Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. Chu X, Dong C, Lei R, Sun L, Wang Z, Dong Y, Shen M, Wang Y, Wang B, Zhang K, Yang L, Li Y, Yuan W, Wang Y, Song H, Jin L, Xiong M, Huang W. Genes Immun; 2009 Apr 15; 10(3):260-6. PubMed ID: 19262575 [Abstract] [Full Text] [Related]
5. Linkage Analysis of the Chromosome 5q31-33 Region Identifies JAKMIP2 as a Risk Factor for Graves' Disease in the Chinese Han Population. Li J, Teng W, Yu Y, Hou X, Shan Z. Med Sci Monit; 2019 Feb 23; 25():1439-1451. PubMed ID: 30796769 [Abstract] [Full Text] [Related]
9. Thyroid stimulating hormone receptor (TSHR) intron 1 variants are major risk factors for Graves' disease in three European Caucasian cohorts. Płoski R, Brand OJ, Jurecka-Lubieniecka B, Franaszczyk M, Kula D, Krajewski P, Karamat MA, Simmonds MJ, Franklyn JA, Gough SC, Jarząb B, Bednarczuk T. PLoS One; 2010 Nov 25; 5(11):e15512. PubMed ID: 21124799 [Abstract] [Full Text] [Related]
10. Use of Tag single nucleotide polymorphisms (SNPs) to screen PTPN21: no association with Graves' disease. Zeitlin AA, Heward JM, Brand OJ, Newby PR, Franklyn JA, Gough SC, Simmonds MJ. Clin Endocrinol (Oxf); 2006 Sep 25; 65(3):380-4. PubMed ID: 16918960 [Abstract] [Full Text] [Related]
11. Association of the TSHR gene with Graves' disease: the first disease specific locus. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC. Eur J Hum Genet; 2005 Nov 25; 13(11):1223-30. PubMed ID: 16106256 [Abstract] [Full Text] [Related]
12. Association of Fc receptor-like 5 (FCRL5) with Graves' disease is secondary to the effect of FCRL3. Simmonds MJ, Brand OJ, Barrett JC, Newby PR, Franklyn JA, Gough SC. Clin Endocrinol (Oxf); 2010 Nov 25; 73(5):654-60. PubMed ID: 20626413 [Abstract] [Full Text] [Related]
13. Predisposition to Graves' disease and Graves' ophthalmopathy by genetic variants of IL2RA. Du J, Wang X, Tan G, Wei W, Zhou F, Liang Z, Li H, Yu H. J Mol Med (Berl); 2021 Oct 25; 99(10):1487-1495. PubMed ID: 34287665 [Abstract] [Full Text] [Related]
14. Association Between Secretoglobin Family 3A Member 2 (SCGB3A2) Gene Polymorphisms and Asthma in a Korean Population. Kim SK, Seok H, Park HJ, Han K, Kang SW, Ban JY, Jung HJ, Kim KI, Lee BJ, Kim J, Chung JH. Med Sci Monit; 2017 Apr 19; 23():1880-1885. PubMed ID: 28422086 [Abstract] [Full Text] [Related]
15. The association of SCGB3A2 polymorphisms with the risk of Graves' disease: a meta-analysis. Xue L, Han B, Pan C, Song H. Endocrine; 2014 Apr 19; 45(3):365-9. PubMed ID: 23934357 [Abstract] [Full Text] [Related]
16. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Tomer Y, Concepcion E, Greenberg DA. Thyroid; 2002 Dec 19; 12(12):1129-35. PubMed ID: 12593727 [Abstract] [Full Text] [Related]
17. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population. Imrie H, Vaidya B, Perros P, Kelly WF, Toft AD, Young ET, Kendall-Taylor P, Pearce SH. J Clin Endocrinol Metab; 2001 Feb 19; 86(2):626-30. PubMed ID: 11158020 [Abstract] [Full Text] [Related]
18. Association of the interleukin-2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC. Clin Endocrinol (Oxf); 2007 Apr 19; 66(4):508-12. PubMed ID: 17371467 [Abstract] [Full Text] [Related]
19. A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC. Clin Endocrinol (Oxf); 2004 Aug 19; 61(2):269-72. PubMed ID: 15272925 [Abstract] [Full Text] [Related]
20. A dense mapping study of six European AITD susceptibility regions in a large Chinese Han Cohort of Graves' disease. Liu W, Zhang QY, Yuan FF, Wang HN, Zhang LL, Ma YR, Ye XP, Zhang MM, Song ZY, Li SX, Du WH, Liang J, Zhang XM, Gao GQ, Zhao SX, Chen FL, Song HD, China Consortium for the Genetics of Autoimmune Thyroid Disease. Clin Endocrinol (Oxf); 2018 Dec 19; 89(6):840-848. PubMed ID: 30176063 [Abstract] [Full Text] [Related] Page: [Next] [New Search]